Ceredex Value Advisors LLC boosted its holdings in shares of Raymond James (NYSE:RJF – Free Report) by 191.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 722,393 shares of the financial services provider’s stock after acquiring an additional 474,443 shares during the quarter. Raymond James accounts for about 1.7% of Ceredex Value Advisors LLC’s investment portfolio, making the stock its 13th largest holding. Ceredex Value Advisors LLC owned 0.35% of Raymond James worth $88,464,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the business. AGF Management Ltd. lifted its holdings in Raymond James by 17.2% in the 2nd quarter. AGF Management Ltd. now owns 2,580,467 shares of the financial services provider’s stock worth $318,972,000 after purchasing an additional 378,033 shares during the last quarter. Earnest Partners LLC lifted its holdings in Raymond James by 1.5% in the 2nd quarter. Earnest Partners LLC now owns 2,505,369 shares of the financial services provider’s stock worth $309,689,000 after purchasing an additional 37,173 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Raymond James by 1.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,215,996 shares of the financial services provider’s stock worth $273,919,000 after purchasing an additional 25,494 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Raymond James by 6.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,024,612 shares of the financial services provider’s stock worth $250,238,000 after purchasing an additional 113,826 shares during the last quarter. Finally, APG Asset Management N.V. increased its position in Raymond James by 2.1% in the 2nd quarter. APG Asset Management N.V. now owns 1,874,140 shares of the financial services provider’s stock worth $216,153,000 after buying an additional 38,695 shares during the period. 83.83% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have commented on RJF shares. Wells Fargo & Company lifted their price target on Raymond James from $140.00 to $152.00 and gave the stock an “overweight” rating in a research report on Thursday, October 24th. Morgan Stanley lifted their price target on Raymond James from $132.00 to $145.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Bank of America lifted their price target on Raymond James from $136.00 to $152.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. The Goldman Sachs Group boosted their price objective on Raymond James from $125.00 to $142.00 and gave the company a “neutral” rating in a research report on Thursday, October 24th. Finally, UBS Group lowered their price objective on Raymond James from $138.00 to $135.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 9th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $140.91.
Insider Transactions at Raymond James
In other news, CEO Tashtego S. Elwyn sold 31,277 shares of the stock in a transaction on Monday, August 12th. The stock was sold at an average price of $109.64, for a total transaction of $3,429,210.28. Following the sale, the chief executive officer now owns 35,380 shares in the company, valued at approximately $3,879,063.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 9.74% of the company’s stock.
Raymond James Stock Performance
Shares of NYSE:RJF opened at $144.29 on Friday. The business’s fifty day moving average price is $127.40 and its two-hundred day moving average price is $122.16. Raymond James has a fifty-two week low of $97.05 and a fifty-two week high of $151.59. The stock has a market capitalization of $29.72 billion, a price-to-earnings ratio of 14.86, a price-to-earnings-growth ratio of 0.75 and a beta of 0.98. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.02 and a quick ratio of 0.99.
Raymond James (NYSE:RJF – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.54. The company had revenue of $3.46 billion for the quarter, compared to analyst estimates of $3.32 billion. Raymond James had a return on equity of 19.61% and a net margin of 13.86%. The business’s revenue was up 13.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.13 earnings per share. As a group, analysts predict that Raymond James will post 10.73 EPS for the current fiscal year.
Raymond James Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 1.25%. The ex-dividend date was Tuesday, October 1st. Raymond James’s payout ratio is presently 18.54%.
Raymond James Company Profile
Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.
Further Reading
- Five stocks we like better than Raymond James
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Battle of the Retailers: Who Comes Out on Top?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding RJF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Raymond James (NYSE:RJF – Free Report).
Receive News & Ratings for Raymond James Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raymond James and related companies with MarketBeat.com's FREE daily email newsletter.